Data from A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
Torsten O. Nielsen(University of British Columbia), Matthew J. Ellis(University of California, Davis), Tammi L. Vickery(Washington University in St. Louis), Samuel Leung(BC Cancer Agency), Inge J. Stijleman, Jerry Reed(Washington University in St. Louis), Elaine R. Mardis(Nationwide Children's Hospital), Joel S. Parker(University of North Carolina at Chapel Hill), Mark Ebbert(University of Kentucky), Charles M. Perou(University of North Carolina at Chapel Hill), Sherri R. Davies(Washington University in St. Louis), Jacqueline Snider(Washington University in St. Louis), Maggie C.U. Cheang(Institute of Cancer Research), David Voduc(BC Cancer Agency), Philip S. Bernard(University of Utah)
Cited by 0
Related Papers
A global reference for human genetic variation
|Nature|2015|20.3k
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k